Another great podcast by Tres Uramigas on ESMO GU updates!

Ahead of SUNNIFORECAST results, do you use Ipi/Nivo for Non-clear cell RCC? pubmed.ncbi.nlm.nih.gov/35210307/ults

Thank you for being one of the Tres Uramigas!!

Podcast with Ira Mellman coming soon!!

Charis was a friend and trusted colleague during my time in Cleveland. She taught me a great deal about RCC genetics. The world of renal cancer and genetics is better because of her work.

The Cancer Immunity Cycle has been updated! Listen to the details here as Ira Mellman breaks down this update. spotifyanchor-web.app.link/e/U3CbGVSIbMb

In participants with advanced renal-cell carcinoma, belzutifan, a HIF-2α inhibitor, was superior to everolimus, an mTOR inhibitor, with respect to progression-free survival and tumor response. Read the full LITESPARK-005 trial results: nej.md/4cvmO2R

POLL Ahead of ESMO - Eur. Oncology 2024 talk on nccRCC: what is your preferred 1st L regimen for advanced, papillary RCC? Vote below! Sumanta K. Pal, MD, FASCO Brian Rini, MD Tom Powles Naomi Haas Uromigos Brian Shuch, MD Neeraj Agarwal, MD, FASCO Yousef Zakharia Rana McKay, MD, FASCO Ulka Vaishampayan Benjamin L Maughan Laura Esfeller

Dr. Powles of the Uromigos sinks his teeth into ctDNA as an emerging, powerful tool to monitor prostate patients on therapy and how it may add to existing prognostic models…

⚡️What happens when “pastamigos” meet Uromigos 😃 Served with love 🍝🍽️ 🎧 Petros Grivas Brian Rini, MD Tom Powles

Congrats to Moshe Ornstein MD and team for demonstrating the feasibility of an intermittent ipi/nivo approach in their Phase II trial, showing potential for prolonged treatment-free intervals. 🌟📊 Looking forward to more studies like this! #RCC clinical-genitourinary-cancer.com/article/S1558-…

Thank you Brian Rini, MD and Tom Powles for inviting me to discuss prostate cancer hormonal therapy resistance on Uromigos! podcasters.spotify.com/pod/show/the-u…

A late entry using a method usually reserved for kidnapping and ransom notes- but still good Barts Experimental Cancer Medicine Centre OncoAlert Toni Choueiri, MD Brian Rini, MD

Kristen you are inspiring ❤️

Amazing #ESMO24 GU highlights by Uromigos in their recent episode with Brian Rini, MD Tom Powles silke gillessen . Will be an interesting conference this year. podcasts.apple.com/gb/podcast/the…

👀 Katy Beckermann previews various clinical trials and studies to be presented at #ESMO24, including those on #immunotherapy for #metastatic #KidneyCancer. 👉 Watch Now: buff.ly/4e81vFS

We have a @uromigos Nashville 24 golden ticket 🎫 winner Dimitra Bakaloudi MD, MS for 27th and 28th Sept 👏👏☀️☀️. Session include MIBC, new ADCs, papillary RCC, cellular therapies and the Uromigos cup with 🇯🇵 and Tres Uramigas 🇺🇸 🇪🇸 🇲🇽 teams . New trial designs and defining oligomet RCC…

The Vanderbilt University Ingram Cancer Center Genitourinary team is expanding. We are seeking a GU medical oncology clinical investigator to join our innovative team. Please message me or Brian Rini, MD to inquire further. We will also be at #ESMO24

📺Check out the exciting events in store for #UromigosLive2024 in Nashville! Follow us here on X and visit GUOncologyNow.com for updates: guoncologynow.com/conference/the… 📢 Live streaming of sessions starts 9/27 at 2:00pm ET!